Insulin Glargine (U-100) Vials and Tapentadol Extended-Release Tablets
Determining the interaction of Insulin Glargine (U-100) Vials and Tapentadol Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: Tapentadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Vials-Tapentadol Hydrochloride
- Insulin Glargine (U-100) Vials-Tapentadol Tablets
- Insulin Glargine (U-100) Vials-TaperDex 12-day
- Insulin Glargine (U-100) Vials-TaperDex 6-day
- Insulin Glargine (U-100) Vials-TaperDex 7-day
- Insulin Glargine (U-100) Vials-Tar Distillate Topical
- Tapentadol Extended-Release Tablets-Insulin Glargine (U-300) Pens
- Tapentadol Extended-Release Tablets-Insulin glargine and lixisenatide
- Tapentadol Extended-Release Tablets-Insulin glargine and lixisenatide Subcutaneous
- Tapentadol Extended-Release Tablets-Insulin glargine, recombinant Subcutaneous
- Tapentadol Extended-Release Tablets-Insulin glulisine
- Tapentadol Extended-Release Tablets-Insulin Glulisine (Cartridges and Pens)